Wilmington, Delaware, United States, May 02, 2023 (GLOBE NEWSWIRE) -- The global mice model market stood at USD 1.5 billion in 2020 and the global market is projected to reach USD 2.3 billion by 2028. The global industry is anticipated to expand at a CAGR of 6.2% between 2021 and 2028.
The market value of mice models is increasing due to the increasing demand for personalized medicine, which is on rise, and mice models play a crucial role in developing personalized therapies. Mice models are used to study the efficacy and safety of drugs in pre-clinical trials, which helps to identify the right dosage and treatment for a specific patient. As personalized medicine becomes more prevalent, the demand for mice models is expected to grow.
Download a Sample for Highlights on Market Drivers and Challenges Affecting the Mice Model: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085
Market Scope:
| Report Coverage | Details | |
| Market Revenue | USD 1.5 billion in 2020 | |
| Market Value | USD 2.3 billion by 2028 | |
| Growth Rate | 6.2% | |
| Forecast Period | 2021–2028 | |
| No. of Pages | 155 Pages | |
| Market Segmentation | By Type, Specialty and Service | |
| Regions Covered | North America, Europe, Asia Pacific, Middle East & Africa, South America | |
| Companies Covered | Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, Taconic Biosciences, Inc., TransGenic, Inc | |
The rising prevalence of chronic diseases is another significant factor contributing to the market growth. Chronic diseases such as cancer, diabetes, and cardiovascular diseases are on the rise globally. Mice models are extensively used in the study of these diseases and the development of new treatments. As the prevalence of chronic diseases increases, the demand for mice models for research purposes is expected to grow.
The market prospects have been driven by factors such as technological advancements over the analysis period. Advancements in technology have made it easier to manipulate the genes of mice models and create specific genetic modifications that mimic human diseases. This has opened up new avenues for research and drug development. The development of new techniques such as CRISPR/Cas9 gene editing has made it easier to create more precise and accurate mice models, which has further increased their utility in research.
Key Findings of the Market Report
- On the basis of type, the knockout segment is likely to be most preferred, expected to expand at a significant share, attributed to the factors such as the rising demand for personalized medicine, and the development of new gene editing technologies.
- Based on specialty, oncology holds a significant market share, due to an increase in research activities in the field of cancer biology worldwide.
- By service, genetically engineered mouse models (GEMMs) are expected to boost the market growth, attributed to factors including an increase in research activities in the field of genetics and genomics, the development of new gene editing technologies, and the availability of a large number of genetically engineered mouse models.
Get Customization on this Report for Specific Research Solutions at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2085
Global Mice Model Market: Growth Drivers
- The global Mice Model market is projected to expand at a steady pace from 2021 to 2028, due to the increasing awareness regarding the importance of animal models in research.
- Another factor that is projected to augment the market growth includes the expansion of the pharmaceutical and biotechnology industries.
- Additionally, growing focus on precision medicine, as well as increasing availability of genetically engineered mice models are major factors that are anticipated to fuel the market prospects in the near future.
Global Mice Model Market: Regional Landscape
- North America is expected to dominate the Mice Model market during the forecast period, attributed to high prevalence of chronic diseases such as cancer and diabetes in the region.
- The regional market is witnessing an increase, due to the factors such as presence of major pharmaceutical and biotechnology companies, as well as technological advancements in mice model generation.
- Favorable government initiatives, and rising demand for personalized medicine are anticipated to escalate the growth of the regional market over the analysis period.
Global Mice Model Market: Key Players
- Charles River Laboratories
- Crescendo Biologics Limited
- Deltagen, Inc.
- GenOway S.A.
- Harlan Laboratories, Inc.
- ImmunoGenes AG
- Taconic Biosciences, Inc.
- Lexicon Pharmaceuticals
- SAGE Labs
- The Jackson Laboratory
- Taconic Biosciences, Inc.
- TransGenic, Inc.
- Others
Competitive Landscape
Prominent players in the Mice Model industry are taking advantage of the rapidly increasing demand for Mice Model. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale providers. Some prominent market developments are as follows:
- In March 2021, Charles River Laboratories International, Inc. announced the acquisition of Cognate BioServices, Inc., a leading cell and gene therapy CDMO (contract development and manufacturing organization), to expand its cell and gene therapy offerings and capabilities.
- In February 2021, The Jackson Laboratory and Nanjing Biotech Innovation Center (NBIC) announced a strategic partnership to provide mouse model breeding and technical services to researchers in China.
- In January 2021, Taconic Biosciences announced the expansion of its CRISPR gene editing capabilities to include rat models, in addition to mouse models.
Grow your profit margin with Transparency Market Research – Buy the Report Now!
Global Mice Model Market: Segmentation
Type
- Transgenic Mice Model
- Hybrid / Congenic Mice Model
- Knockout Mice Model
- Carcinogen-induced & Spontaneous Mice Model
- Outbred Mice Model
- Inbred Mice Model
- Transplantation Mice Model
- Conditioned / Surgically Modified Mice Model
Specialty
- Immunology
- Central Nervous System (CNS)
- Oncology
- Cardiovascular
- Diabetes
- Metabolism & Regulation
Service
- Breeding & Rederivation Services
- Cryopreservation & Cryorecovery Services
- Quarantine Services
- Genetic Testing Services
- Model In-licensing Services
- In Vivo & In Vitro Pharmacology Services
- Genetically Engineered Model Services
- Other Services (Surgical and Line Rescue)
Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
